TIMP2 and cancer: Nakopoulou [17] and Jones [36] observed comparable immuno-activity of TIMP-2 in breast primary cancer cells and fibroblasts, while Garbett and colleagues reported heightened TIMP-2 expression in tumor cells compared to fibroblasts and inflammatory cells [36].